Projects per year
Fingerprint
Dive into the research topics where Martha Lacy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mayo Clinic Multiple Myeloma SPORE
Bergsagel, L., Braggio, E. D., Vachon, C. M., Chesi, M., Dueck, A., Fonseca, R., Geyer, S., Jelinek, D. F., Lacy, M. & Stewart, A. K.
9/1/15 → 8/31/24
Project: Research project
-
Project 1: Optimizing a VSV-based virotherapy-based regimen for advanced MM
Lacy, M. & Lacy, M. M. Q.
9/15/21 → 8/31/23
Project: Research project
-
Academic Promotions in Medicine: An Appraisal of Fairness
Warsame, R., Kim, Y. H., Ouk, M. Y., Mara, K. C., Lacy, M. Q., Hayes, S. N., Shalle, Z., Balls-Berry, J., Jordan, B. L., Enders, F. T., Wolanskyj-Spinner, A. P. & Spinner, R. J., Mar 2024, In: Mayo Clinic proceedings. 99, 3, p. 424-434 11 p.Research output: Contribution to journal › Article › peer-review
-
Mode of progression in smoldering multiple myeloma: a study of 406 patients
Abdallah, N. H., Lakshman, A., Kumar, S. K., Cook, J., Binder, M., Kapoor, P., Dispenzieri, A., Gertz, M. A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Dingli, D., Lin, Y., Kourelis, T., Warsame, R., Bergsagel, L. & Rajkumar, S. V., Dec 2024, In: Blood cancer journal. 14, 1, 9.Research output: Contribution to journal › Article › peer-review
Open Access -
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
Goel, U., Charalampous, C., Kapoor, P., Binder, M., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonder, A., Gertz, M. A., Gonsalves, W. I., Hayman, S. R., Hobbs, M. A., Hwa, Y. L., Kourelis, T., Lacy, M. Q., Leung, N., Lin, Y., Warsame, R. M., Kyle, R. A., Rajkumar, S. V., & 1 others , Dec 2024, In: Blood cancer journal. 14, 1, 55.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up
Abdallah, N., Witzig, T. E., Kumar, S. K., Lacy, M. Q., Hayman, S. R., Dispenzieri, A., Roy, V., Gertz, M. A., Bergsagel, P. L. & Rajkumar, S. V., 2024, (Accepted/In press) In: Leukemia.Research output: Contribution to journal › Letter › peer-review
-
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma
Goldman-Mazur, S., Visram, A., Rajkumar, S. V., Kapoor, P., Dispenzieri, A., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Hayman, S. R., Dingli, D., Kourelis, T., Gonsalves, W., Warsame, R., Muchtar, E., Leung, N., Kyle, R. A. & Kumar, S. K., Mar 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 3, p. e104-e111.e1Research output: Contribution to journal › Article › peer-review